BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33630347)

  • 1. Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization.
    Zhang Y; Jin L; Zhang X; Bai R; Chen D; Ma Y; Zhai X
    Pharmacoepidemiol Drug Saf; 2021 May; 30(5):636-643. PubMed ID: 33630347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital admissions caused by adverse drug events: an Australian prospective study.
    Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
    Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Events Detected by Clinical Pharmacists in an Emergency Department: A Prospective Monocentric Observational Study.
    Laureau M; Vuillot O; Gourhant V; Perier D; Pinzani V; Lohan L; Faucanie M; Macioce V; Marin G; Giraud I; Jalabert A; Villiet M; Castet-Nicolas A; Sebbane M; Breuker C
    J Patient Saf; 2021 Dec; 17(8):e1040-e1049. PubMed ID: 32175969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
    Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
    BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
    Cragg A; Small SS; Lau E; Rowe A; Lau A; Butcher K; Hohl CM
    Drug Saf; 2023 Nov; 46(11):1161-1172. PubMed ID: 37783974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency department.
    Chen YC; Huang HH; Fan JS; Chen MH; Hsu TF; Yen DH; Huang MS; Wang CY; Huang CI; Lee CH
    Medicine (Baltimore); 2015 Feb; 94(7):e547. PubMed ID: 25700322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China.
    He W; Yao D; Hu Y; Dai H
    Ther Clin Risk Manag; 2018; 14():2139-2147. PubMed ID: 30464487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
    Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of emergency department pharmacists on drug overuse and drug underuse in patients with an ADE-related hospitalisation: a controlled intervention study.
    Rahman RN; Nikolik B; de Ridder MAJ; Hoek AE; Janssen MJA; Schuit SCE; Karapinar-Çarkit F; van den Bemt PMLA
    BMC Health Serv Res; 2022 Nov; 22(1):1363. PubMed ID: 36397102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.
    Roulet L; Asseray N; Dary M; Chiffoleau A; Potel G; Ballereau F
    Int J Clin Pharm; 2012 Dec; 34(6):902-10. PubMed ID: 22923368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).
    Lombardi N; Crescioli G; Bettiol A; Tuccori M; Capuano A; Bonaiuti R; Mugelli A; Venegoni M; Vighi GD; Vannacci A;
    Front Pharmacol; 2020; 11():412. PubMed ID: 32327995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.
    Bates DW; Spell N; Cullen DJ; Burdick E; Laird N; Petersen LA; Small SD; Sweitzer BJ; Leape LL
    JAMA; 1997 Jan 22-29; 277(4):307-11. PubMed ID: 9002493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of pharmacist interventions in pediatric ambulatory care clinics.
    Yung E; McNicol M; Lewis D; Fischer J; Petkus K; Sebastian S; Abdel-Rasoul M; Schmuhl K; Wise K
    J Am Pharm Assoc (2003); 2021; 61(2):198-205.e1. PubMed ID: 33358098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential cost savings by prevention of adverse drug events with a novel medication review program.
    Fernández EV; Warriner CL; David T; Gordon E; Twigg G; Carroll NV
    J Am Pharm Assoc (2003); 2020; 60(3):462-469.e4. PubMed ID: 31948934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
    Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
    J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug events in hospitalized elderly.
    Gray SL; Sager M; Lestico MR; Jalaluddin M
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M59-63. PubMed ID: 9467435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
    Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
    BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Adverse Drug Events with Hospitalization Outcomes and Costs in Older Adults in the USA using the Nationwide Readmissions Database.
    Riaz M; Brown JD
    Pharmaceut Med; 2019 Aug; 33(4):321-329. PubMed ID: 31933184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.